Literature DB >> 17854814

Asymmetric development of peripheral atherosclerosis in patients with erectile dysfunction: an ultrasonographic study.

Carlo Foresta1, Pierfrancesco Palego, Mirko Schipilliti, Riccardo Selice, Alberto Ferlin, Nicola Caretta.   

Abstract

Recent literature focused on erectile dysfunction (ED) as a reliable predictive parameter of cardiovascular diseases. ED patients have a higher prevalence of atherosclerotic lesions (increased intima-media thickness and plaques) at carotid site, but data on femoral site are still lacking. Nevertheless, there is accumulating evidence concerning a significant involvement of femoral atherosclerosis in other clinical conditions associated to ED, such as diabetes mellitus and coronary disease. Therefore, we investigated the prevalence of carotid and femoral atherosclerotic lesions and penile peak systolic velocity (PSV) in 238 ED patients by Eco-Colour Doppler ultrasonography (US). We found - irrespective of the presence of cardiovascular risk factors - a significant increase of atherosclerotic lesions in ED group with respect to 52 controls (66.4% versus 36.5%) and a higher prevalence of atherosclerosis at the femoral site (23.1% versus 5.7%), also with respect to the carotid site (8%). Moreover, PSV was significantly lower in ED patients with atherosclerosis compared to those without atherosclerotic lesions (41.9+/-15.3 cm/s versus 55.2+/-17.7 cm/s), and it was particularly low in those with combined carotid and femoral atherosclerosis (34.8+/-13.3 cm/s) and those with isolated carotid atherosclerosis (37.9+/-13.0 cm/s). These data confirm the strong relation between atherosclerosis and ED, an asymmetric development of atherosclerotic lesions in ED patients and suggest to perform an US study of both femoral and carotid district in these subjects.

Entities:  

Mesh:

Year:  2007        PMID: 17854814     DOI: 10.1016/j.atherosclerosis.2007.08.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Significant improvement of erectile function after Roux-en-Y gastric bypass surgery in obese Chinese men with erectile dysfunction.

Authors:  Li Kun; Zhang Pin; Di Jianzhong; Han Xiaodong; Yu Haoyong; Bao Yuqian; Zhang Hongwei
Journal:  Obes Surg       Date:  2015-05       Impact factor: 4.129

2.  Hypovitaminosis D is associated with erectile dysfunction in type 2 diabetes.

Authors:  Nicola Caretta; Saula Vigili de Kreutzenberg; Umberto Valente; Gabriella Guarneri; Alberto Ferlin; Angelo Avogaro; Carlo Foresta
Journal:  Endocrine       Date:  2016-01-12       Impact factor: 3.633

Review 3.  The Association of Erectile Dysfunction and Cardiovascular Disease: A Systematic Critical Review.

Authors:  Omer A Raheem; Jeannie J Su; Joel R Wilson; Tung-Chin Hsieh
Journal:  Am J Mens Health       Date:  2016-02-04

4.  Peripheral atherosclerosis in patients with arterial erectile dysfunction.

Authors:  C Goksu; M Deveer; A K Sivrioglu; P Goksu; B Cucen; S Parlak; M Cetinkaya; L Altin
Journal:  Int J Impot Res       Date:  2013-10-17       Impact factor: 2.896

5.  Metabolic syndrome and erectile dysfunction: the ultrasound evaluation of cavernosal atherosclerosis.

Authors:  Mirko Schipilliti; Nicola Caretta; Pierfrancesco Palego; Riccardo Selice; Alberto Ferlin; Carlo Foresta
Journal:  Diabetes Care       Date:  2011-07-05       Impact factor: 19.112

6.  Analysis of cardiovascular risks for erectile dysfunction in Chinese patients with type 2 diabetes mellitus lacking clinical symptoms of cardiovascular diseases.

Authors:  Penghui Yuan; Delin Ma; Yucong Zhang; Xintao Gao; Jiaxin Wang; Rui Li; Zhuo Liu; Tao Wang; Yan Yang; Gang Yuan; Xuefeng Yu; Shaogang Wang; Jihong Liu; Xiaming Liu
Journal:  Transl Androl Urol       Date:  2020-12

7.  Low Serum 25-Hydroxyvitamin D Level as a Potential Risk Factor of Erectile Dysfunction in Elderly Men with Moderate to Severe Lower Urinary Tract Symptoms.

Authors:  Hyung Suk Kim; Min Chul Cho
Journal:  World J Mens Health       Date:  2021-02-17       Impact factor: 5.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.